{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:29:06Z","timestamp":1790872146264,"version":"4.1.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100023652","name":"University of Rijeka","doi-asserted-by":"crossref","award":["uniri- mladi-biomed-23-54"],"award-info":[{"award-number":["uniri- mladi-biomed-23-54"]}],"id":[{"id":"10.13039\/501100023652","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100023652","name":"University of Rijeka","doi-asserted-by":"crossref","award":["uniri-iskusni-biomed-23-285"],"award-info":[{"award-number":["uniri-iskusni-biomed-23-285"]}],"id":[{"id":"10.13039\/501100023652","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100023652","name":"University of Rijeka","doi-asserted-by":"crossref","award":["uniri-iskusni-biomed-23-243"],"award-info":[{"award-number":["uniri-iskusni-biomed-23-243"]}],"id":[{"id":"10.13039\/501100023652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02114-2","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:54:10Z","timestamp":1771084450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exosomal MicroRNAs as theranostic tools in type 2 diabetes and its complications: mechanistic insights and clinical implications"],"prefix":"10.1186","volume":"18","author":[{"given":"Iva","family":"Vukeli\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Art","family":"Sefedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijana","family":"Detel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun\u010dica","family":"Buljevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav","family":"\u0160u\u0161a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Tesovnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Raheli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Klobu\u010dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"2114_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01951-9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01951-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"2114_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020;21(17):6275.","journal-title":"Int J Mol Sci"},{"issue":"7785","key":"2114_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576(7785):51\u201360.","journal-title":"Nature"},{"issue":"3","key":"2114_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031094","volume":"26","author":"E M\u0142ynarska","year":"2025","unstructured":"M\u0142ynarska E, Czarnik W, Dzie\u017ca N, J\u0119draszak W, Majchrowicz G, Prusinowski F, et al. Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. Int J Mol Sci. 2025;26(3):1094.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2114_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrendo.2016.86","volume":"12","author":"AA Tahrani","year":"2016","unstructured":"Tahrani AA, Barnett AH, Bailey CJ. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nat Rev Endocrinol. 2016;12(10):566\u201392.","journal-title":"Nat Rev Endocrinol"},{"key":"2114_CR6","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed NA, McCoy RG, Aleppo G, Bajaj M, Balapattabi K et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142025. Diabetes Care. 2025;48(Supplement_1):S181\u2013206. Available from: https:\/\/diabetesjournals.org\/care\/article\/48\/Supplement_1\/S181\/157569\/9-Pharmacologic-Approaches-to-Glycemic-Treatment"},{"issue":"7258","key":"2114_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405\u201312.","journal-title":"BMJ"},{"key":"2114_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1143067","author":"A Mansour","year":"2023","unstructured":"Mansour A, Mousa M, Abdelmannan D, Tay G, Hassoun A, Alsafar H. Microvascular and macrovascular complications of type 2 diabetes mellitus: exome wide association analyses. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1143067.","journal-title":"Front Endocrinol"},{"issue":"9735","key":"2114_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124\u201336.","journal-title":"Lancet"},{"key":"2114_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1305378","author":"J Yan","year":"2023","unstructured":"Yan J, Li B, Chen Y, Gu C, Dai G, Zhang Q, et al. Prevalence and predictors of developing vision-threatening diabetic retinopathy within the first three years of type 2 diabetes. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1305378.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2114_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/clinem\/dgad452","volume":"109","author":"L Fernandes Silva","year":"2023","unstructured":"Fernandes Silva L, Hokkanen J, Vangipurapu J, Oravilahti A, Laakso M. Metabolites as risk factors for diabetic retinopathy in patients with type 2 diabetes: a 12-year follow-up study. J Clin Endocrinol Metab. 2023;109(1):100\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2114_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jdiacomp.2016.11.019","volume":"31","author":"L Fogelfeld","year":"2017","unstructured":"Fogelfeld L, Hart P, Miernik J, Ko J, Calvin D, Tahsin B, et al. Combined diabetes-renal multifactorial intervention in patients with advanced diabetic nephropathy: proof-of-concept. J Diabetes Complications. 2017;31(3):624\u201330.","journal-title":"J Diabetes Complications"},{"issue":"5","key":"2114_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol. 2021;17(5):319\u201334.","journal-title":"Nat Rev Nephrol"},{"key":"2114_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1212-8","author":"CW Hicks","year":"2019","unstructured":"Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019. https:\/\/doi.org\/10.1007\/s11892-019-1212-8.","journal-title":"Curr Diab Rep"},{"key":"2114_CR15","doi-asserted-by":"publisher","first-page":"110758","DOI":"10.1016\/j.diabres.2023.110758","volume":"206","author":"AJM Boulton","year":"2023","unstructured":"Boulton AJM. A brief overview of the diabetic neuropathies. Diabetes Res Clin Pract. 2023;206:110758.","journal-title":"Diabetes Res Clin Pract"},{"key":"2114_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0092-1","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019. https:\/\/doi.org\/10.1038\/s41572-019-0092-1.","journal-title":"Nat Rev Dis Primers"},{"key":"2114_CR17","doi-asserted-by":"crossref","unstructured":"Verrotti A, Prezioso G, Scattoni R, Chiarelli F. Autonomic neuropathy in diabetes mellitus. Front Endocrinol. 2014;5.","DOI":"10.3389\/fendo.2014.00205"},{"key":"2114_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3693","author":"D Ziegler","year":"2023","unstructured":"Ziegler D, Herder C, Papanas N. Neuropathy in prediabetes. Diabetes Metab Res Rev. 2023. https:\/\/doi.org\/10.1002\/dmrr.3693.","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"2114_CR19","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553\u201379.","journal-title":"Diabetes Care"},{"issue":"8","key":"2114_CR20","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.12998\/wjcc.v11.i8.1684","volume":"11","author":"JM Raja","year":"2023","unstructured":"Raja JM, Maturana MA, Kayali S, Khouzam A, Efeovbokhan N. Diabetic foot ulcer: a comprehensive review of pathophysiology and management modalities. World J Clin Cases. 2023;11(8):1684\u201393.","journal-title":"World J Clin Cases"},{"issue":"3","key":"2114_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.dsx.2015.04.007","volume":"9","author":"S Noor","year":"2015","unstructured":"Noor S, Zubair M, Ahmad J. Diabetic foot ulcer\u2014a review on pathophysiology, classification and microbial etiology. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2015;9(3):192\u20139.","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"issue":"12","key":"2114_CR22","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.4239\/wjd.v13.i12.1106","volume":"13","author":"G Akkus","year":"2022","unstructured":"Akkus G, Sert M. Diabetic foot ulcers: a devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities. World J Diabetes. 2022;13(12):1106\u201321.","journal-title":"World J Diabetes"},{"key":"2114_CR23","doi-asserted-by":"publisher","first-page":"108615","DOI":"10.1016\/j.biopha.2019.108615","volume":"112","author":"S Patel","year":"2019","unstructured":"Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to Pace wound healing. Biomed Pharmacother. 2019;112:108615.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"2114_CR24","first-page":"1072","volume":"57","author":"JL Burgess","year":"2021","unstructured":"Burgess JL, Wyant WA, Abdo Abujamra B, Kirsner RS, Jozic I. Diabetic wound-healing science. Med (Mex). 2021;57(10):1072.","journal-title":"Med (Mex)"},{"key":"2114_CR25","doi-asserted-by":"publisher","unstructured":"Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018;1411(1):153\u201365. Available from: https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/nyas.13569","DOI":"10.1111\/nyas.13569"},{"key":"2114_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01553-4","author":"JL Huo","year":"2023","unstructured":"Huo JL, Feng Q, Pan S, Fu WJ, Liu Z, Liu Z. Diabetic cardiomyopathy: early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions. Cell Death Discov. 2023. https:\/\/doi.org\/10.1038\/s41420-023-01553-4.","journal-title":"Cell Death Discov"},{"issue":"9","key":"2114_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585\u2013607.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"2114_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-014-0476-2","volume":"14","author":"A Jayaraman","year":"2014","unstructured":"Jayaraman A, Pike CJ. Alzheimer\u2019s disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr Diab Rep. 2014;14(4):476.","journal-title":"Curr Diab Rep"},{"key":"2114_CR29","doi-asserted-by":"crossref","unstructured":"Dove A, Wang J, Huang H, Dunk MM, Sakakibara S, Guitart-Masip M et al. Diabetes, Prediabetes, and Brain Aging: The Role of Healthy Lifestyle. Diabetes Care. 2024;47(10):1794\u2013802. Available from: https:\/\/diabetesjournals.org\/care\/article\/47\/10\/1794\/157163\/Diabetes-Prediabetes-and-Brain-Aging-The-Role-of","DOI":"10.2337\/dc24-0860"},{"key":"2114_CR30","doi-asserted-by":"publisher","unstructured":"Chauhan A, Dubey S, Jain S. Association Between Type 2 Diabetes Mellitus and Alzheimer\u2019s Disease: Common Molecular Mechanism and Therapeutic Targets. Cell Biochem Funct. 2024;42(7):e4111. Available from: https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/cbf.4111","DOI":"10.1002\/cbf.4111"},{"issue":"5","key":"2114_CR31","doi-asserted-by":"publisher","first-page":"e70053","DOI":"10.1002\/dmrr.70053","volume":"41","author":"T Lorenzo","year":"2025","unstructured":"Lorenzo T, Ngandu T, Lehtisalo J, Antikainen R, Gispert JD, Kemppainen N, et al. Associations of Prediabetes, diabetes and Glucose-Related markers with cognition and neuroimaging in a 2\u2010Year multidomain lifestyle randomised controlled trial. Diabetes Metab Res Rev. 2025;41(5):e70053.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2114_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01645-y","volume":"16","author":"Z Li","year":"2024","unstructured":"Li Z, Lin C, Cai X, Lv F, Yang W, Ji L. Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials. Alzheimers Res Ther. 2024;16(1):272.","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"2114_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100199","volume":"12","author":"A Cohen","year":"2025","unstructured":"Cohen A, Levine SZ, Vainstein G, Beeri MS, Weinstein G. New-generation antidiabetic medications and dementia risk in older adults with type 2 diabetes: a retrospective cohort study. J Prev Alzheimers Dis. 2025;12(8):100199.","journal-title":"J Prev Alzheimers Dis"},{"key":"2114_CR34","doi-asserted-by":"crossref","unstructured":"Correction to. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(5):e12451.","DOI":"10.1002\/jev2.12451"},{"issue":"9","key":"2114_CR35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41592-021-01206-3","volume":"18","author":"FJ Verweij","year":"2021","unstructured":"Verweij FJ, Balaj L, Boulanger CM, Carter DRF, Compeer EB, D\u2019Angelo G, et al. The power of imaging to understand extracellular vesicle biology in vivo. Nat Methods. 2021;18(9):1013\u201326.","journal-title":"Nat Methods"},{"key":"2114_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1167717","author":"IS Sohal","year":"2023","unstructured":"Sohal IS, Kasinski AL. Emerging diversity in extracellular vesicles and their roles in cancer. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1167717.","journal-title":"Front Oncol"},{"key":"2114_CR37","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Siljander PR, \u2010M., Andreu Z, Bedina Zavec A, Borr\u00e0s FE, Buzas EI et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4(1)."},{"key":"2114_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"key":"2114_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100608","volume":"19","author":"C Chen","year":"2023","unstructured":"Chen C, Zhang Z, Gu X, Sheng X, Xiao L, Wang X. Exosomes: new regulators of reproductive development. Mater Today Bio. 2023;19:100608.","journal-title":"Mater Today Bio"},{"key":"2114_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1085057","author":"P Gangadaran","year":"2023","unstructured":"Gangadaran P, Madhyastha H, Madhyastha R, Rajendran RL, Nakajima Y, Watanabe N, et al. The emerging role of exosomes in innate immunity, diagnosis and therapy. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2022.1085057.","journal-title":"Front Immunol"},{"issue":"1","key":"2114_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/22115528113020020001","volume":"2","author":"MF Ribeiro","year":"2013","unstructured":"Ribeiro MF, Zhu H, Millard RW, Fan GC. Exosomes function in pro- and anti-angiogenesis. Curr Angiogenes. 2013;2(1):54\u20139.","journal-title":"Curr Angiogenes"},{"key":"2114_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2018.08.007","volume":"75\u201376","author":"NK Karamanos","year":"2019","unstructured":"Karamanos NK, Theocharis AD, Neill T, Iozzo RV. Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases. Matrix Biol. 2019;75\u201376:1\u201311.","journal-title":"Matrix Biol"},{"key":"2114_CR43","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9(1).","DOI":"10.1186\/s13578-019-0282-2"},{"key":"2114_CR44","doi-asserted-by":"crossref","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19(1).","DOI":"10.1186\/s12964-021-00730-1"},{"issue":"8","key":"2114_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9081061","volume":"9","author":"MI Mosquera-Heredia","year":"2021","unstructured":"Mosquera-Heredia MI, Morales LC, Vidal OM, Barcel\u00f3 E, Silvera-Redondo C, V\u00e9lez JI, et al. Exosomes: potential disease biomarkers and new therapeutic targets. Biomedicines. 2021;9(8):1061.","journal-title":"Biomedicines"},{"issue":"1","key":"2114_CR46","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"key":"2114_CR47","doi-asserted-by":"publisher","unstructured":"Pegtel DM, Gould SJ, Exosomes. Annu Rev Biochem. 2019;88(1):487\u2013514. Available from: https:\/\/www.annualreviews.org\/doi\/https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111902","DOI":"10.1146\/annurev-biochem-013118-111902"},{"issue":"1","key":"2114_CR48","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.30087","volume":"4","author":"T Lener","year":"2015","unstructured":"Lener T, Gimona M, Aigner L, B\u00f6rger V, Buzas E, Camussi G, et al. Applying extracellular vesicles based therapeutics in clinical trials \u2013 an ISEV position paper. J Extracell Vesicles. 2015;4(1):30087.","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"2114_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s12276-019-0223-5","volume":"51","author":"DE Murphy","year":"2019","unstructured":"Murphy DE, De Jong OG, Brouwer M, Wood MJ, Lavieu G, Schiffelers RM, et al. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp Mol Med. 2019;51(3):32.","journal-title":"Exp Mol Med"},{"issue":"6478","key":"2114_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.","journal-title":"Science"},{"key":"2114_CR51","doi-asserted-by":"crossref","unstructured":"Satyadev N, Rivera MI, Nikolov NK, Fakoya AOJ. Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications. Front Physiol. 2023;14.","DOI":"10.3389\/fphys.2023.1241096"},{"key":"2114_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.756581","author":"Y Sun","year":"2021","unstructured":"Sun Y, Tao Q, Wu X, Zhang L, Liu Q, Wang L. The utility of exosomes in diagnosis and therapy of diabetes mellitus and associated complications. Front Endocrinol. 2021. https:\/\/doi.org\/10.3389\/fendo.2021.756581.","journal-title":"Front Endocrinol"},{"issue":"7","key":"2114_CR53","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/diabetology5070052","volume":"5","author":"I Vukeli\u0107","year":"2024","unstructured":"Vukeli\u0107 I, \u0160u\u0161a B, Klobu\u010dar S, Buljevi\u0107 S, Liberati Pr\u0161o AM, Belan\u010di\u0107 A, et al. Exosome-derived microRNAs: bridging the gap between obesity and type 2 diabetes in diagnosis and treatment. Diabetologia. 2024;5(7):706\u201324.","journal-title":"Diabetologia"},{"key":"2114_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01607","author":"F Zatterale","year":"2020","unstructured":"Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020. https:\/\/doi.org\/10.3389\/fphys.2019.01607.","journal-title":"Front Physiol"},{"issue":"1","key":"2114_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10753-021-01559-z","volume":"45","author":"L Al-Mansoori","year":"2022","unstructured":"Al-Mansoori L, Al-Jaber H, Prince MS, Elrayess MA. Role of inflammatory cytokines, growth factors and adipokines in adipogenesis and insulin resistance. Inflammation. 2022;45(1):31\u201344.","journal-title":"Inflammation"},{"issue":"48","key":"2114_CR56","doi-asserted-by":"publisher","first-page":"12158","DOI":"10.1073\/pnas.1808855115","volume":"115","author":"C Casta\u00f1o","year":"2018","unstructured":"Casta\u00f1o C, Kalko S, Novials A, P\u00e1rrizas M. Obesity-associated exosomal MiRNAs modulate glucose and lipid metabolism in mice. Proc Natl Acad Sci USA. 2018;115(48):12158\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2114_CR57","doi-asserted-by":"publisher","first-page":"16692","DOI":"10.1002\/jcp.28354","volume":"234","author":"B Zhang","year":"2019","unstructured":"Zhang B, Yang Y, Xiang L, Zhao Z, Ye R. Adipose-derived exosomes: a novel adipokine in obesity\u2010associated diabetes. J Cell Physiol. 2019;234(10):16692\u2013702.","journal-title":"J Cell Physiol"},{"issue":"4","key":"2114_CR58","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1159\/000492252","volume":"48","author":"M Song","year":"2018","unstructured":"Song M, Han L, Chen F, fang, Wang D, Wang F, Zhang L, et al. Adipocyte-Derived exosomes carrying Sonic Hedgehog mediate M1 macrophage Polarization-Induced insulin resistance via Ptch and PI3K pathways. Cell Physiol Biochem. 2018;48(4):1416\u201332.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"2114_CR59","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.2337\/db09-0216","volume":"58","author":"Z Deng","year":"2009","unstructured":"Deng Z, Poliakov A, Hardy RW, Clements R, Liu C, Liu Y, et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes. 2009;58(11):2498\u2013505.","journal-title":"Diabetes"},{"issue":"5","key":"2114_CR60","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/oby.20679","volume":"22","author":"MEG Kranendonk","year":"2014","unstructured":"Kranendonk MEG, Visseren FLJ, Van Balkom BWM, Nolte-\u2019t Hoen ENM, Van Herwaarden JA, De Jager W, et al. Human adipocyte extracellular vesicles in reciprocal signaling between adipocytes and macrophages. Obesity. 2014;22(5):1296\u2013308.","journal-title":"Obesity"},{"issue":"23","key":"2114_CR61","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1007\/s00018-021-03973-w","volume":"78","author":"HY Kwan","year":"2021","unstructured":"Kwan HY, Chen M, Xu K, Chen B. The impact of obesity on adipocyte-derived extracellular vesicles. Cell Mol Life Sci. 2021;78(23):7275\u201388.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"2114_CR62","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jmcb\/mjw040","volume":"8","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Mei H, Chang X, Chen F, Zhu Y, Han X. Adipocyte-derived microvesicles from obese mice induce M1 macrophage phenotype through secreted miR-155. J Mol Cell Biol. 2016;8(6):505\u201317.","journal-title":"J Mol Cell Biol"},{"issue":"11","key":"2114_CR63","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/oby.22616","volume":"27","author":"JB Tryggestad","year":"2019","unstructured":"Tryggestad JB, Teague AM, Sparling DP, Jiang S, Chernausek SD. Macrophage-derived microRNA\u2010155 increases in obesity and influences adipocyte metabolism by targeting peroxisome Proliferator\u2010Activated receptor gamma. Obesity. 2019;27(11):1856\u201364.","journal-title":"Obesity"},{"issue":"2","key":"2114_CR64","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1172\/JCI123069","volume":"129","author":"Y Pan","year":"2019","unstructured":"Pan Y, Hui X, Hoo RLC, Ye D, Chan CYC, Feng T, et al. Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation. J Clin Invest. 2019;129(2):834\u201349.","journal-title":"J Clin Invest"},{"key":"2114_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2016.10.004","volume":"180","author":"M Zhang","year":"2016","unstructured":"Zhang M, Zhou Z, Wang J, Li S. Mir-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-\u03b3. Immunol Lett. 2016;180:1\u20138.","journal-title":"Immunol Lett"},{"key":"2114_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100889","author":"D Zhang","year":"2022","unstructured":"Zhang D, Yao X, Teng Y, Zhao T, Lin L, Li Y, et al. Adipocytes-derived exosomal microRNA\u20101224 inhibits M2 macrophage polarization in obesity\u2010induced adipose tissue inflammation via MSI2\u2010mediated Wnt\/\u03b2\u2010catenin axis. Mol Nutr Food Res. 2022. https:\/\/doi.org\/10.1002\/mnfr.202100889.","journal-title":"Mol Nutr Food Res"},{"key":"2114_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.651996","author":"LM Lei","year":"2021","unstructured":"Lei LM, Lin X, Xu F, Shan SK, Guo B, Li FXZ, et al. Exosomes and obesity-related insulin resistance. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.651996.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2114_CR68","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","volume":"171","author":"W Ying","year":"2017","unstructured":"Ying W, Riopel M, Bandyopadhyay G, Dong Y, Birmingham A, Seo JB, et al. Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity. Cell. 2017;171(2):372-384.e12.","journal-title":"Cell"},{"key":"2114_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00779-x","author":"C Li","year":"2021","unstructured":"Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan JK, et al. Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther. 2021. https:\/\/doi.org\/10.1038\/s41392-021-00779-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2114_CR70","doi-asserted-by":"publisher","first-page":"351","DOI":"10.7150\/ijbs.28522","volume":"15","author":"SY Dang","year":"2019","unstructured":"Dang SY, Leng Y, Wang ZX, Xiao X, Zhang X, Wen T, et al. Exosomal transfer of obesity adipose tissue for decreased miR-141-3p mediate insulin resistance of hepatocytes. Int J Biol Sci. 2019;15(2):351\u201368.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"2114_CR71","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s42255-021-00444-1","volume":"3","author":"Y Ji","year":"2021","unstructured":"Ji Y, Luo Z, Gao H, Dos Reis FCG, Bandyopadhyay G, Jin Z, et al. Hepatocyte-derived exosomes from early onset obese mice promote insulin sensitivity through miR-3075. Nat Metab. 2021;3(9):1163\u201374.","journal-title":"Nat Metab"},{"key":"2114_CR72","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.molmet.2019.11.012","volume":"31","author":"H Mziaut","year":"2020","unstructured":"Mziaut H, Henniger G, Ganss K, Hempel S, Wolk S, McChord J, et al. MiR-132 controls pancreatic beta cell proliferation and survival through Pten\/Akt\/Foxo3 signaling. Mol Metab. 2020;31:150\u201362.","journal-title":"Mol Metab"},{"issue":"3","key":"2114_CR73","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease \u2013 a global public health perspective. J Hepatol. 2019;70(3):531\u201344.","journal-title":"J Hepatol"},{"issue":"2","key":"2114_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000603","volume":"18","author":"H Xu","year":"2020","unstructured":"Xu H, Du X, Xu J, Zhang Y, Tian Y, Liu G, et al. Pancreatic \u03b2 cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving \u03b2 cell function. PLoS Biol. 2020;18(2):e3000603.","journal-title":"PLoS Biol"},{"issue":"2","key":"2114_CR75","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s42255-024-01214-5","volume":"7","author":"TV Rohm","year":"2025","unstructured":"Rohm TV, Cunha E, Rocha K, Olefsky JM. Metabolic messengers: small extracellular vesicles. Nat Metab. 2025;7(2):253\u201362.","journal-title":"Nat Metab"},{"key":"2114_CR76","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.metabol.2017.09.006","volume":"78","author":"X Cui","year":"2018","unstructured":"Cui X, You L, Zhu L, Wang X, Zhou Y, Li Y, et al. Change in Circulating MicroRNA profile of obese children indicates future risk of adult diabetes. Metabolism. 2018;78:95\u2013105.","journal-title":"Metabolism"},{"key":"2114_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.468","author":"X He","year":"2021","unstructured":"He X, Kuang G, Wu Y, Ou C. Emerging roles of exosomal miRNAs in diabetes mellitus. Clin Transl Med. 2021. https:\/\/doi.org\/10.1002\/ctm2.468.","journal-title":"Clin Transl Med"},{"key":"2114_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3107","author":"C Casta\u00f1o","year":"2019","unstructured":"Casta\u00f1o C, Novials A, P\u00e1rrizas M. Exosomes and diabetes. Diabetes Metab Res Rev. 2019. https:\/\/doi.org\/10.1002\/dmrr.3107.","journal-title":"Diabetes Metab Res Rev"},{"issue":"13","key":"2114_CR79","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1089\/ars.2016.6844","volume":"27","author":"TA Kamalden","year":"2017","unstructured":"Kamalden TA, Macgregor-Das AM, Kannan SM, Dunkerly-Eyring B, Khaliddin N, Xu Z, et al. Exosomal MicroRNA-15a transfer from the pancreas augments diabetic complications by inducing oxidative stress. Antioxid Redox Signal. 2017;27(13):913\u201330.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2114_CR80","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.diabres.2010.11.006","volume":"91","author":"LL Sun","year":"2011","unstructured":"Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. Microrna-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract. 2011;91(1):94\u2013100.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"2114_CR81","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.18632\/aging.101689","volume":"10","author":"Q Fu","year":"2018","unstructured":"Fu Q, Jiang H, Wang Z, Wang X, Chen H, Shen Z, et al. Injury factors alter miRNAs profiles of exosomes derived from islets and circulation. Aging. 2018;10(12):3986\u201399.","journal-title":"Aging"},{"issue":"10","key":"2114_CR82","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.2337\/db07-1614","volume":"57","author":"A El Ouaamari","year":"2008","unstructured":"El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, Van Obberghen E. miR-375 targets 3\u2032-phosphoinositide\u2013dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic \u03b2-cells. Diabetes. 2008;57(10):2708\u201317.","journal-title":"Diabetes"},{"issue":"7014","key":"2114_CR83","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature03076","volume":"432","author":"MN Poy","year":"2004","unstructured":"Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, MacDonald PE, et al. A pancreatic islet-specific MicroRNA regulates insulin secretion. Nature. 2004;432(7014):226\u201330.","journal-title":"Nature"},{"issue":"10","key":"2114_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186480","volume":"12","author":"I Song","year":"2017","unstructured":"Song I, Roels S, Martens GA, Bouwens L. Circulating microRNA-375 as biomarker of pancreatic beta cell death and protection of beta cell mass by cytoprotective compounds. PLoS One. 2017;12(10):e0186480.","journal-title":"PLoS One"},{"issue":"14","key":"2114_CR85","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1073\/pnas.0810550106","volume":"106","author":"MN Poy","year":"2009","unstructured":"Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, et al. miR-375 maintains normal pancreatic \u03b1- and \u03b2-cell mass. Proc Natl Acad Sci USA. 2009;106(14):5813\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2114_CR86","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2337\/db18-0470","volume":"68","author":"M Katayama","year":"2019","unstructured":"Katayama M, Wiklander OPB, Fritz T, Caidahl K, El-Andaloussi S, Zierath JR, et al. Circulating Exosomal miR-20b-5p is elevated in type 2 diabetes and could impair insulin action in human skeletal muscle. Diabetes. 2019;68(3):515\u201326.","journal-title":"Diabetes"},{"key":"2114_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201904044","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Chen L, Yan C, Zhou W, Endo Y, Liu J, et al. Circulating exosomal miR-20b\u20105p inhibition restores Wnt9b signaling and reverses diabetes\u2010associated impaired wound healing. Small. 2020. https:\/\/doi.org\/10.1002\/smll.201904044.","journal-title":"Small"},{"issue":"6","key":"2114_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna9060067","volume":"9","author":"KV Dracheva","year":"2023","unstructured":"Dracheva KV, Pobozheva IA, Anisimova KA, Balandov SG, Grunina MN, Hamid ZM, et al. Downregulation of exosomal hsa-miR-551b-3p in obesity and its link to type 2 diabetes mellitus. Non-coding RNA. 2023;9(6):67.","journal-title":"Non-coding RNA"},{"issue":"6","key":"2114_CR89","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1172\/JCI75438","volume":"125","author":"X Fu","year":"2015","unstructured":"Fu X, Dong B, Tian Y, Meng Z, Wang X, Pattou F, et al. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids. J Clin Invest. 2015;125(6):2497\u2013509.","journal-title":"J Clin Invest"},{"issue":"5","key":"2114_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101621","volume":"12","author":"W Wang","year":"2025","unstructured":"Wang W, Ma D, Chen Y, Cheng R, Zhang T, Ge Q, et al. miR-146b\/Btg2 axis as a potential inducer of islet beta-cell decline during the progression of obesity to T2DM. Genes & Diseases. 2025;12(5):101621.","journal-title":"Genes & Diseases"},{"issue":"4","key":"2114_CR91","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56(4):836\u201349.","journal-title":"Exp Mol Med"},{"issue":"9","key":"2114_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092039","volume":"12","author":"A Caturano","year":"2024","unstructured":"Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D, et al. Modern challenges in type 2 diabetes: balancing new medications with multifactorial care. Biomedicines. 2024;12(9):2039.","journal-title":"Biomedicines"},{"issue":"02","key":"2114_CR93","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1055\/s-0042-116314","volume":"125","author":"S Tang","year":"2016","unstructured":"Tang S, Luo F, Feng Y, Wei X, Miao H, Lu Y, et al. Neutral ceramidase secreted via exosome protects against palmitate-induced apoptosis in INS-1 cells. Exp Clin Endocrinol Diabetes. 2016;125(02):130\u20135.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"2114_CR94","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00125-016-3882-y","volume":"59","author":"A Jalabert","year":"2016","unstructured":"Jalabert A, Vial G, Guay C, Wiklander OPB, Nordin JZ, Aswad H, et al. Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice. Diabetologia. 2016;59(5):1049\u201358.","journal-title":"Diabetologia"},{"key":"2114_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.154006","volume":"103","author":"J Wu","year":"2020","unstructured":"Wu J, Dong T, Chen T, Sun J, Luo J, He J, et al. Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte. Metabolism. 2020;103:154006.","journal-title":"Metabolism"},{"key":"2114_CR96","doi-asserted-by":"crossref","unstructured":"Sangalli E, Tagliabue E, Sala LL, Prattichizzo F, Uccellatore A, Spada D et al. Circulating MicroRNA-15a associates with retinal damage in patients with early stage type 2 diabetes. Front Endocrinol. 2020;11.","DOI":"10.3389\/fendo.2020.00254"},{"key":"2114_CR97","first-page":"3695","volume":"18","author":"S Yang","year":"2023","unstructured":"Yang S, Zhang J, Zeng T, Zheng J, Min J, Chen L. Role of circulating exosomal miRNA-3976 in early diabetic retinopathy. Int J Nanomed. 2023;18:3695\u2013709.","journal-title":"Int J Nanomed"},{"issue":"15","key":"2114_CR98","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.21037\/atm-20-5189","volume":"9","author":"Z Smit-McBride","year":"2021","unstructured":"Smit-McBride Z, Morse LS. MicroRNA and diabetic retinopathy\u2014biomarkers and novel therapeutics. Ann Transl Med. 2021;9(15):1280\u20131280.","journal-title":"Ann Transl Med"},{"issue":"19","key":"2114_CR99","doi-asserted-by":"publisher","first-page":"10502","DOI":"10.3390\/ijms221910502","volume":"22","author":"A Milluzzo","year":"2021","unstructured":"Milluzzo A, Maugeri A, Barchitta M, Sciacca L, Agodi A. Epigenetic mechanisms in type 2 diabetes retinopathy: a systematic review. Int J Mol Sci. 2021;22(19):10502.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2114_CR100","doi-asserted-by":"publisher","first-page":"E374","DOI":"10.1152\/ajpendo.00021.2018","volume":"315","author":"Z Liang","year":"2018","unstructured":"Liang Z, Gao KP, Wang YX, Liu ZC, Tian L, Yang XZ, et al. RNA sequencing identified specific Circulating MiRNA biomarkers for early detection of diabetes retinopathy. Am J Physiol-Endocrinol Metab. 2018;315(3):E374\u201385.","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"12","key":"2114_CR101","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1530\/EC-19-0446","volume":"8","author":"ER Polina","year":"2019","unstructured":"Polina ER, Oliveira FM, Sbruzzi RC, Crispim D, Canani LH, Santos KG. Gene polymorphism and plasma levels of miR-155 in diabetic retinopathy. Endocr Connect. 2019;8(12):1591\u20139.","journal-title":"Endocr Connect"},{"key":"2114_CR102","doi-asserted-by":"publisher","first-page":"10767","DOI":"10.2147\/IJN.S475234","volume":"19","author":"Y Song","year":"2024","unstructured":"Song Y, Yin C, Kong N. Stem cell-derived exosomes: natural intercellular messengers with versatile mechanisms for the treatment of diabetic retinopathy. Int J Nanomed. 2024;19:10767\u201384.","journal-title":"Int J Nanomed"},{"issue":"1","key":"2114_CR103","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1167\/iovs.18-25617","volume":"60","author":"W Zhang","year":"2019","unstructured":"Zhang W, Wang Y, Kong Y. Exosomes derived from mesenchymal stem cells modulate miR-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting HMGB1. Invest Ophthalmol Vis Sci. 2019;60(1):294.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2114_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1412138","author":"H Zhao","year":"2024","unstructured":"Zhao H, Cai Y, Pan J, Chen Q. Role of microRNA in linking diabetic retinal neurodegeneration and vascular degeneration. Front Endocrinol. 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1412138.","journal-title":"Front Endocrinol"},{"key":"2114_CR105","doi-asserted-by":"publisher","DOI":"10.1177\/1849454418807827","volume":"7","author":"A Safwat","year":"2018","unstructured":"Safwat A, Sabry D, Ragiae A, Amer E, Mahmoud R, Shamardan R. Adipose mesenchymal stem cells\u2013derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits. J Circ Biomark. 2018;7:184945441880782.","journal-title":"J Circ Biomark"},{"key":"2114_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119232","volume":"272","author":"X Cao","year":"2021","unstructured":"Cao X, Xue LD, Di Y, Li T, Tian YJ, Song Y. MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p\/XBP1 axis. Life Sci. 2021;272:119232.","journal-title":"Life Sci"},{"issue":"2","key":"2114_CR107","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ncrna.2023.02.001","volume":"8","author":"A Sufianov","year":"2023","unstructured":"Sufianov A, Kostin A, Begliarzade S, Kudriashov V, Ilyasova T, Liang Y, et al. Exosomal non coding rnas as a novel target for diabetes mellitus and its complications. Non-coding RNA Research. 2023;8(2):192\u2013204.","journal-title":"Non-coding RNA Research"},{"key":"2114_CR108","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jprot.2013.10.037","volume":"96","author":"I Zubiri","year":"2014","unstructured":"Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E, Martin-Lorenzo M, Gonzalez-Calero L, et al. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. J Proteomics. 2014;96:92\u2013102.","journal-title":"J Proteomics"},{"key":"2114_CR109","doi-asserted-by":"crossref","unstructured":"Zang J, Maxwell AP, Simpson DA, McKay GJ. Differential expression of urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in individuals with diabetic kidney disease. Sci Rep. 2019;9(1).","DOI":"10.1038\/s41598-019-47504-x"},{"issue":"3","key":"2114_CR110","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1631\/jzus.B1600490","volume":"19","author":"Z Yao","year":"2018","unstructured":"Yao Z, Chen W, Shao S, Ma S, Yang C, Li M, et al. Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders. Journal of Zhejiang University-SCIENCE B. 2018;19(3):183\u201398.","journal-title":"Journal of Zhejiang University-SCIENCE B"},{"key":"2114_CR111","doi-asserted-by":"crossref","unstructured":"Deli\u0107 D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PLoS One. 2016;11(3):e0150154.","DOI":"10.1371\/journal.pone.0150154"},{"issue":"6","key":"2114_CR112","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/nep.14039","volume":"27","author":"AK Gonz\u00e1lez-Palomo","year":"2022","unstructured":"Gonz\u00e1lez-Palomo AK, P\u00e9rez\u2010V\u00e1zquez FJ, M\u00e9ndez\u2010Rodr\u00edguez KB, Ilizaliturri\u2010Hern\u00e1ndez CA, Cardona\u2010Alvarado MI, Flores\u2010Nicasio MV, et al. Profile of urinary exosomal <Emphasis Type=\"SmallCaps\">microRNAs<\/Emphasis> and their contribution to diabetic kidney disease through a predictive classification model. Nephrology. 2022;27(6):484\u201393.","journal-title":"Nephrology"},{"issue":"2","key":"2114_CR113","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s10753-014-9961-7","volume":"38","author":"X Lin","year":"2015","unstructured":"Lin X, You Y, Wang J, Qin Y, Huang P, Yang F. MicroRNA-155 deficiency promotes nephrin acetylation and attenuates renal damage in hyperglycemia-induced nephropathy. Inflammation. 2015;38(2):546\u201354.","journal-title":"Inflammation"},{"key":"2114_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1983-3","author":"H Kim","year":"2019","unstructured":"Kim H, Bae YU, Jeon JS, Noh H, Park HK, Byun DW, et al. The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy. J Transl Med. 2019. https:\/\/doi.org\/10.1186\/s12967-019-1983-3.","journal-title":"J Transl Med"},{"key":"2114_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8719060","volume":"2019","author":"J Tang","year":"2019","unstructured":"Tang J, Yao D, Yan H, Chen X, Wang L, Zhan H. The role of micrornas in the pathogenesis of diabetic nephropathy. Int J Endocrinol. 2019;2019:1\u20138.","journal-title":"Int J Endocrinol"},{"issue":"7","key":"2114_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076214","volume":"24","author":"J Szostak","year":"2023","unstructured":"Szostak J, Gor\u0105cy A, Durys D, Dec P, Modrzejewski A, Pawlik A. The role of microrna in the pathogenesis of diabetic nephropathy. Int J Mol Sci. 2023;24(7):6214.","journal-title":"Int J Mol Sci"},{"key":"2114_CR117","doi-asserted-by":"crossref","unstructured":"Rahimi A, Nikooei S, Roozbehi K, Semirani-Nezhad D, Larki RA, Arya A et al. Circulating levels of miR-155 and CTBP1-AS2 as a promising biomarker for early detection of diabetic nephropathy. Biochem Genet. 2025.","DOI":"10.1007\/s10528-025-11176-2"},{"key":"2114_CR118","doi-asserted-by":"publisher","DOI":"10.1049\/2024\/5702517","author":"S Zheng","year":"2024","unstructured":"Zheng S, Zeng Y, Chu L, Gong T, Li S, Yang M, et al. Renal tissue-derived exosomal miRNA\u201034a in diabetic nephropathy induces renal tubular cell fibrosis by promoting the polarization of M1 macrophages. IET Nanobiotechnol. 2024. https:\/\/doi.org\/10.1049\/2024\/5702517.","journal-title":"IET Nanobiotechnol"},{"key":"2114_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1177-1","author":"J Jin","year":"2019","unstructured":"Jin J, Shi Y, Gong J, Zhao L, Li Y, He Q, et al. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther. 2019. https:\/\/doi.org\/10.1186\/s13287-019-1177-1.","journal-title":"Stem Cell Res Ther"},{"key":"2114_CR120","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2147\/DMSO.S286191","volume":"14","author":"Y Hao","year":"2021","unstructured":"Hao Y, Miao J, Liu W, Cai K, Huang X, Peng L. Mesenchymal stem cell-derived exosomes carry MicroRNA-125a to protect against diabetic nephropathy by targeting histone deacetylase 1 and downregulating Endothelin-1. Diabetes Metab Syndr Obes Targets Ther. 2021;14:1405\u201318.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"2114_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00997-y","author":"YC Tsai","year":"2023","unstructured":"Tsai YC, Kuo MC, Hung WW, Wu PH, Chang WA, Wu LY, et al. Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer. Cell Commun Signal. 2023. https:\/\/doi.org\/10.1186\/s12964-022-00997-y.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"2114_CR122","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5493\/wjem.v8.i3.18","volume":"8","author":"E Xourgia","year":"2018","unstructured":"Xourgia E, Papazafiropoulou A, Melidonis A. Circulating micrornas as biomarkers for diabetic neuropathy: a novel approach. World J Exp Med. 2018;8(3):18\u201323.","journal-title":"World J Exp Med"},{"issue":"6","key":"2114_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061632","volume":"11","author":"A Khan","year":"2022","unstructured":"Khan A, Pasquier J, Ramachandran V, Ponirakis G, Petropoulos IN, Chidiac O, et al. Altered circulating microRNAs in patients with diabetic neuropathy and corneal nerve loss: a pilot study. J Clin Med. 2022;11(6):1632.","journal-title":"J Clin Med"},{"key":"2114_CR124","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.diabres.2017.06.005","volume":"130","author":"S Wan","year":"2017","unstructured":"Wan S, Wang J, Wang J, Wu J, Song J, Zhang CY, et al. Increased serum miR-7 is a promising biomarker for type 2 diabetes mellitus and its microvascular complications. Diabetes Res Clin Pract. 2017;130:171\u20139.","journal-title":"Diabetes Res Clin Pract"},{"key":"2114_CR125","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2147\/DMSO.S467409","volume":"17","author":"H Ji","year":"2024","unstructured":"Ji H, Lu Y, Liu G, Zhao X, Xu M, Chen M. Role of decreased expression of miR-155 and miR-146a in peripheral blood of type 2 diabetes mellitus patients with diabetic peripheral neuropathy. Diabetes Metab Syndr Obes. 2024;17:2747\u201360.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"2114_CR126","doi-asserted-by":"publisher","first-page":"623","DOI":"10.17219\/acem\/131217","volume":"30","author":"X Wu","year":"2021","unstructured":"Wu X, Wang X, Yin Y, Zhu L, Zhang F, Yang J. Investigation of the role of miR-221 in diabetic peripheral neuropathy and related molecular mechanisms. Adv Clin Exp Med. 2021;30(6):623\u201332.","journal-title":"Adv Clin Exp Med"},{"issue":"12","key":"2114_CR127","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1096\/fj.201800597R","volume":"32","author":"L Jia","year":"2018","unstructured":"Jia L, Chopp M, Wang L, Lu X, Szalad A, Zhang ZG. Exosomes derived from high-glucose\u2010stimulated Schwann cells promote development of diabetic peripheral neuropathy. FASEB J. 2018;32(12):6911\u201322.","journal-title":"FASEB J"},{"issue":"2","key":"2114_CR128","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00125-019-05043-0","volume":"63","author":"B Fan","year":"2020","unstructured":"Fan B, Li C, Szalad A, Wang L, Pan W, Zhang R, et al. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2020;63(2):431\u201343.","journal-title":"Diabetologia"},{"key":"2114_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113694","volume":"341","author":"B Fan","year":"2021","unstructured":"Fan B, Chopp M, Zhang ZG, Liu XS. Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy. Exp Neurol. 2021;341:113694.","journal-title":"Exp Neurol"},{"issue":"11","key":"2114_CR130","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s40618-019-01053-2","volume":"42","author":"CJ Lin","year":"2019","unstructured":"Lin CJ, Lan YM, Ou MQ, Ji LQ, Lin SD. Expression of miR-217 and HIF-1\u03b1\/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats. J Endocrinol Invest. 2019;42(11):1307\u201317.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2114_CR131","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/wrr.12850","volume":"28","author":"X Li","year":"2020","unstructured":"Li X, Tang Y, Jia Z, Zhao X, Chen M. Decreased expression of <Emphasis Type=\"SmallCaps\">miR<\/Emphasis>-24 in peripheral plasma of type 2 diabetes mellitus patients associated with diabetic foot ulcer. Wound Repair Regen. 2020;28(6):728\u201338.","journal-title":"Wound Repair Regen"},{"issue":"15","key":"2114_CR132","first-page":"8117","volume":"24","author":"ZJ Chen","year":"2020","unstructured":"Chen ZJ, Shi XJ, Fu LJ, Liu J, Shi K, Zhang WB, et al. Serum and Exosomal hsa_circ_0000907 and hsa_circ_0057362 as novel biomarkers in the early diagnosis of diabetic foot ulcer. Eur Rev Med Pharmacol Sci. 2020;24(15):8117\u201326.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"22","key":"2114_CR133","doi-asserted-by":"publisher","first-page":"11777","DOI":"10.3390\/app122211777","volume":"12","author":"P Ansari","year":"2022","unstructured":"Ansari P, Akther S, Khan JT, Islam SS, Masud MSR, Rahman A, et al. Hyperglycaemia-Linked diabetic foot complications and their management using conventional and alternative therapies. Appl Sci. 2022;12(22):11777.","journal-title":"Appl Sci"},{"issue":"4","key":"2114_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0058-5","volume":"50","author":"X Li","year":"2018","unstructured":"Li X, Xie X, Lian W, Shi R, Han S, Zhang H, et al. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp Mol Med. 2018;50(4):1\u201314.","journal-title":"Exp Mol Med"},{"key":"2114_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-03015-7","author":"ZH Liang","year":"2022","unstructured":"Liang ZH, Pan NF, Lin SS, Qiu ZY, Liang P, Wang J, et al. Exosomes from mmu_circ_0001052-modified adipose-derived stem cells promote angiogenesis of DFU via miR-106a-5p and FGF4\/p38MAPK pathway. Stem Cell Res Ther. 2022. https:\/\/doi.org\/10.1186\/s13287-022-03015-7.","journal-title":"Stem Cell Res Ther"},{"key":"2114_CR136","first-page":"814","volume":"19","author":"B Li","year":"2020","unstructured":"Li B, Luan S, Chen J, Zhou Y, Wang T, Li Z, et al. The MSC-derived exosomal lncRNA H19 promotes wound healing in diabetic foot ulcers by upregulating PTEN via MicroRNA-152-3p. Mol Ther. 2020;19:814\u201326.","journal-title":"Mol Ther"},{"issue":"10","key":"2114_CR137","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.18632\/aging.103143","volume":"12","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Chen L, Yu T, Yan C, Zhou W, Cao F, et al. Inhibition of circulating exosomal microRNA-15a-3p accelerates diabetic wound repair. Aging. 2020;12(10):8968\u201386.","journal-title":"Aging"},{"issue":"18","key":"2114_CR138","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1089\/scd.2021.0100","volume":"30","author":"B Zhao","year":"2021","unstructured":"Zhao B, Zhang X, Zhang Y, Lu Y, Zhang W, Lu S, et al. Human exosomes accelerate cutaneous wound healing by promoting collagen synthesis in a diabetic mouse model. Stem Cells Dev. 2021;30(18):922\u201333.","journal-title":"Stem Cells Dev"},{"key":"2114_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00765-3","author":"X Xiao","year":"2021","unstructured":"Xiao X, Xu M, Yu H, Wang L, Li X, Rak J, et al. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a\/Src. Signal Transduct Target Ther. 2021. https:\/\/doi.org\/10.1038\/s41392-021-00765-3.","journal-title":"Signal Transduct Target Ther"},{"key":"2114_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01075-y","author":"X Xiao","year":"2022","unstructured":"Xiao X, Xu M, Yu H, Wang L, Li X, Rak J, et al. Correction to: Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a\/Src. Signal Transduct Target Ther. 2022. https:\/\/doi.org\/10.1038\/s41392-022-01075-y.","journal-title":"Signal Transduct Target Ther"},{"key":"2114_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01681-z","author":"X Bian","year":"2020","unstructured":"Bian X, Li B, Yang J, Ma K, Sun M, Zhang C, et al. Regenerative and protective effects of dMSC-sEVs on high-glucose-induced senescent fibroblasts by suppressing RAGE pathway and activating Smad pathway. Stem Cell Res Ther. 2020. https:\/\/doi.org\/10.1186\/s13287-020-01681-z.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"2114_CR142","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.7150\/thno.22958","volume":"8","author":"CY Chen","year":"2018","unstructured":"Chen CY, Rao SS, Ren L, Hu XK, Tan YJ, Hu Y, et al. Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics. 2018;8(6):1607\u201323.","journal-title":"Theranostics"},{"issue":"9","key":"2114_CR143","first-page":"2841","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang J, Yu M, Yin W, Liang B, Li A, Li J, et al. Development of a novel RNAi therapy: engineered miR-31 exosomes promoted the healing of diabetic wounds. Bioact Mater. 2021;6(9):2841\u201353.","journal-title":"Bioact Mater"},{"issue":"8","key":"2114_CR144","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.bbadis.2017.03.013","volume":"1863","author":"R Guo","year":"2017","unstructured":"Guo R, Nair S. Role of MicroRNA in diabetic cardiomyopathy: from mechanism to intervention. Biochim Biophys Acta BBA Mol Basis Dis. 2017;1863(8):2070\u20137.","journal-title":"Biochim Biophys Acta BBA Mol Basis Dis"},{"key":"2114_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00070-6","author":"D De Gonzalo-Calvo","year":"2017","unstructured":"De Gonzalo-Calvo D, Van Der Meer RW, Rijzewijk LJ, Smit JWA, Revuelta-Lopez E, Nasarre L, et al. Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-00070-6.","journal-title":"Sci Rep"},{"key":"2114_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01458-z","author":"S Veitch","year":"2022","unstructured":"Veitch S, Njock MS, Chandy M, Siraj MA, Chi L, Mak H, et al. MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes. Cardiovasc Diabetol. 2022. https:\/\/doi.org\/10.1186\/s12933-022-01458-z.","journal-title":"Cardiovasc Diabetol"},{"key":"2114_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110944","volume":"518","author":"L Tao","year":"2020","unstructured":"Tao L, Huang X, Xu M, Qin Z, Zhang F, Hua F, et al. Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy. Mol Cell Endocrinol. 2020;518:110944.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2114_CR148","doi-asserted-by":"publisher","first-page":"e2277","DOI":"10.1038\/cddis.2016.181","volume":"7","author":"J Xiao","year":"2016","unstructured":"Xiao J, Pan Y, Li XH, Yang XY, Feng YL, Tan HH, et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through Exosomal miR-21 by targeting PDCD4. Cell Death Dis. 2016;7(6):e2277\u20132277.","journal-title":"Cell Death Dis"},{"key":"2114_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13875-2","author":"CU Copier","year":"2017","unstructured":"Copier CU, Le\u00f3n L, Fern\u00e1ndez M, Contador D, Calligaris SD. Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-13875-2.","journal-title":"Sci Rep"},{"issue":"4","key":"2114_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13040479","volume":"13","author":"AB Reiss","year":"2023","unstructured":"Reiss AB, Ahmed S, Johnson M, Saeedullah U, De Leon J. Exosomes in cardiovascular disease: from mechanism to therapeutic target. Metabolites. 2023;13(4):479.","journal-title":"Metabolites"},{"issue":"4","key":"2114_CR151","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/jcp.30969","volume":"238","author":"A Bell-Hensley","year":"2023","unstructured":"Bell-Hensley A, Das S, McAlinden A. The miR\u2010181 family: wide\u2010ranging pathophysiological effects on cell fate and function. J Cell Physiol. 2023;238(4):698\u2013713.","journal-title":"J Cell Physiol"},{"issue":"3","key":"2114_CR152","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/dom.16121","volume":"27","author":"S Yang","year":"2025","unstructured":"Yang S, Yuan Y, Zhang B, Wu T, Yu C, Li F, et al. Identification of adipose tissue-derived Exosomal micro RNA as a novel causal biomarker for cognitive impairment in type 2 diabetes mellitus: triangulating evidence from Mendelian randomization and multicentre population studies. Diabetes Obes Metab. 2025;27(3):1265\u201375.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"2114_CR153","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/1753-0407.13450","volume":"15","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yang S, Zhu W, Niu T, Wang J, Yang M, et al. Exosomal <Emphasis Type=\"SmallCaps\">miR<\/Emphasis> -let\u20107c\u20105p is involved in the cognitive function of type 2 diabetes mellitus patients by interleukin 10: a cross\u2010sectional study. J Diabetes. 2023;15(11):978\u201386.","journal-title":"J Diabetes"},{"key":"2114_CR154","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.2147\/JIR.S429532","volume":"16","author":"Q Ran","year":"2023","unstructured":"Ran Q, Tian H, Lin J, Wang H, Wang B, Chen Z, et al. Mesenchymal stem Cell-Derived exosomes: A novel approach to Diabetes-Associated cognitive impairment. J Inflamm Res. 2023;16:4213\u201328.","journal-title":"J Inflamm Res"},{"issue":"9","key":"2114_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204252","volume":"13","author":"K Kubota","year":"2018","unstructured":"Kubota K, Nakano M, Kobayashi E, Mizue Y, Chikenji T, Otani M, et al. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. PLoS One. 2018;13(9):e0204252.","journal-title":"PLoS One"},{"issue":"1","key":"2114_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/srep24805","volume":"6","author":"M Nakano","year":"2016","unstructured":"Nakano M, Nagaishi K, Konari N, Saito Y, Chikenji T, Mizue Y, et al. Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes. Sci Rep. 2016;6(1):24805.","journal-title":"Sci Rep"},{"issue":"3","key":"2114_CR157","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.350205","volume":"18","author":"HL Lang","year":"2023","unstructured":"Lang HL, Zhao YZ, Xiao RJ, Sun J, Chen Y, Hu GW, et al. Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes. Neural Regen Res. 2023;18(3):609.","journal-title":"Neural Regen Res"},{"issue":"1","key":"2114_CR158","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s10020-023-00727-1","volume":"29","author":"M Wang","year":"2023","unstructured":"Wang M, Xie K, Zhao S, Jia N, Zong Y, Gu W, et al. Aerobic exercise improves cognitive impairment in mice with type 2 diabetes by regulating the MALAT1\/miR-382-3p\/BDNF signaling pathway in serum-exosomes. Mol Med. 2023;29(1):130.","journal-title":"Mol Med"},{"issue":"7","key":"2114_CR159","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202500336R","volume":"39","author":"T Shima","year":"2025","unstructured":"Shima T, Onishi H, Terashima C. Muscle-derived <Emphasis Type=\"SmallCaps\">miR<\/Emphasis> \u2010200a\u20103p through light\u2010intensity exercise may contribute to improve memory dysfunction in type 2 diabetic mice. FASEB J. 2025;39(7):e70531.","journal-title":"FASEB J"},{"issue":"3","key":"2114_CR160","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1210\/clinem\/dgad562","volume":"109","author":"X Liu","year":"2024","unstructured":"Liu X, Zhao Z, Chen D, Zhang Z, Lin X, Shen Z, et al. SIRT1 and miR-34a-5p expression in PBMCs as potential biomarkers for patients with type 2 diabetes with cognitive impairments. J Clin Endocrinol Metab. 2024;109(3):815\u201326.","journal-title":"J Clin Endocrinol Metab"},{"key":"2114_CR161","doi-asserted-by":"publisher","unstructured":"Sun W, Zhao J, Wang W, Zhang W, Feng X, Feng J et al. Effects of Cognitive Intervention and Rehabilitation Training on the Expression of miR-134-5p in Elderly Patients with Diabetes Mellitus and Cognitive Impairment. Exp Aging Res. 2025;51(2):247\u201356. Available from: https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.1080\/0361073X.2024.2377431","DOI":"10.1080\/0361073X.2024.2377431"},{"issue":"8","key":"2114_CR162","doi-asserted-by":"publisher","first-page":"e70196","DOI":"10.1111\/jnc.70196","volume":"169","author":"LCR Teixeira","year":"2025","unstructured":"Teixeira LCR, Pereira JD, Mamede I, Caramelli P, Silva VC, Veloso AA, et al. Common miRNAs, Genes, and regulatory pathways in alzheimer\u2019s disease and type 2 diabetes mellitus: an integrative analysis of systematic Reviews, bioinformatics and data mining. J Neurochem. 2025;169(8):e70196.","journal-title":"J Neurochem"},{"key":"2114_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115087","volume":"165","author":"J Li","year":"2023","unstructured":"Li J, Zhang Y, Dong PY, Yang GM, Gurunathan S. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. Biomed Pharmacother. 2023;165:115087.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2114_CR164","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s12276-023-01132-8","volume":"56","author":"I Jung","year":"2024","unstructured":"Jung I, Shin S, Baek MC, Yea K. Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications. Exp Mol Med. 2024;56(1):19\u201331.","journal-title":"Exp Mol Med"},{"issue":"1","key":"2114_CR165","doi-asserted-by":"publisher","first-page":"3759339","DOI":"10.1155\/2024\/3759339","volume":"2024","author":"W Zheng","year":"2024","unstructured":"Zheng W, Ji X, Yin QQ, Wu C, Xu C, Pan H, et al. Exosomes as emerging regulators of immune responses in type 2 diabetes Mellitus. Yorek M, editor. J Diabetes Res. 2024;2024(1):3759339.","journal-title":"J Diabetes Res"},{"issue":"1","key":"2114_CR166","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06461-y","volume":"23","author":"H Yu","year":"2025","unstructured":"Yu H, Davoudi M, Sadegh-Nejadi S, Miao X, Bagherieh M, Afrisham R. Impact of monotherapy and combination therapy with glucagon-like peptide-1 receptor agonists on exosomal and non-exosomal MicroRNA signatures in type 2 diabetes mellitus: a systematic review. J Transl Med. 2025;23(1):477.","journal-title":"J Transl Med"},{"issue":"1","key":"2114_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01725-5","volume":"17","author":"DL Li","year":"2025","unstructured":"Li DL, Ding XY, He QL, Zhan WH, Long J, He MN, et al. Integrating exosome wide associations study and Mendelian randomization identified causal miRNAs for type 2 diabetes mellitus and its complications. Diabetol Metab Syndr. 2025;17(1):160.","journal-title":"Diabetol Metab Syndr"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02114-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02114-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02114-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:04:21Z","timestamp":1774289061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02114-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2114"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02114-2","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}